Medpace (MEDP) PT Raised to $565 at Baird

March 9, 2026 6:19 AM

Baird analyst Eric Coldwell raised the price target on Medpace (NASDAQ: MEDP) to $565.00 (from $564.00) while maintaining a Outperform rating.

No results found